MSME (Udyam registered) Ministry of MSME
- Udyam number
- UDYAM-UP-29-0004143
Rodec Pharma Limited - pharma in New Delhi, Delhi, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹108.15 Cr
▲ 20% YoY
Net profit · FY 2025
₹18.97 Cr
Net margin 17.5%
EBITDA · FY 2025
₹28.26 Cr
EBITDA margin 26.1%
Authorised capital
₹25 Cr
Registered with MCA
Paid-up capital
₹22.58 Cr
Issued & subscribed
Open charges
₹142.48 Cr
Satisfied ₹8.51 Cr
Company age
29 yrs
Est. 1997
Directors on board
6
As per MCA filings
About Rodec Pharma Limited
Data last updated:
Rodec Pharma Limited is a public limited company based in New Delhi, Delhi, India. It operates in the animal pharmaceuticals and healthcare segment of the pharmaceuticals sector. It was incorporated on 18 November 1997 and has been in existence for over 29 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24233UP1997PLC239832. Its GSTIN is 09AABCR5958E1Z5 (Uttar Pradesh).
The company has an authorised share capital of ₹25 Cr and a paid-up capital of ₹22.58 Cr. It was formerly known as Rodec Pharmaceuticals Private Limited. It is led by directors including Chhaya Gupta and Utkarsh Gupta.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at F – 46 Pankaj Central Market I.P Extension Patparganj, New Delhi, Delhi, India – 110092.
As per the financials filed for FY 2025, the company reported a revenue of ₹108.15 Cr, a growth of 20% compared to the previous year. For the same year it recorded a net profit of ₹18.97 Cr (net margin 17.5%) and EBITDA of ₹28.26 Cr (EBITDA margin 26.1%). Revenue has grown at a compounded annual rate (CAGR) of 24% over three years and 26% over five years.
As per MCA filings, the company has open charges of ₹142.48 Cr and satisfied charges of ₹8.51 Cr on record. Court records list 150 cases involving the company, including 139 filed by the company and 11 filed against it; 34 cases are pending. The company has 8 deals on record (6 secondary share transfers, 2 funding rounds), with disclosed funding of ₹98.6 Lakh; the latest was in March 2024.
Rodec Pharma Limited is registered as an MSME under the Udyam registration framework (Reg. No. UDYAM-UP-29-0004143). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website rodec.in.
Company details
CIN U24233UP1997PLC239832
Registration Number 090729
Incorporation Date 18 November 1997
ROC Delhi
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2024
Date of Balance Sheet 31 March 2024
Compliance Status Active Compliant
MSME Classification MSME
Udyam Registration UDYAM-UP-29-0004143
CIN history
Rodec Pharma has 2 previous CINs, indicating changes in the company's corporate structure or registration details. The current CIN is U24233UP1997PLC239832, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24233UP1997PLC239832 | Current |
| U24233DL1997PTC090729 | Previous |
| U24233DL1997PLC090729 | Previous |
Recognitions & Rankings of Rodec Pharma
Contact details
Rodec Pharma Limited's registered office is in New Delhi, Delhi.
- Social Media
- Registered AddressF – 46 Pankaj Central Market I.P Extension Patparganj, New Delhi, Delhi, India – 110092
- IndustryPharma, Animal Pharmaceuticals & Healthcare
Comprehensive company report
Rodec Pharma Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Rodec Pharma is professional, scientific and technical. In detail, this covers veterinary activities.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| M | Professional, Scientific and Technical | M8 | Veterinary activities |
To see the full business activity and turnover split of Rodec Pharma Limited, buy the company report.
Financials of Rodec Pharma Limited
FY 2024 filings availableRodec Pharma Limited reported revenue of ₹108.15 Cr (up 20% YoY) for FY 2025.
Revenue · FY 2025
₹108.15 Cr ▲ 20%
Net profit · FY 2025
₹18.97 Cr margin 17.5%
EBITDA · FY 2025
₹28.26 Cr margin 26.1%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 20%
3 years · compounded
▲ 24%
5 years · compounded
▲ 26%
EBITDA CAGR growth
1 year
▲ 61%
3 years · compounded
▲ 61%
5 years · compounded
▲ 54%
Revenue has grown at a compounded annual rate (CAGR) of 26% over five years, including 20% growth in the latest year. EBITDA rose 61% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹28.26 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹18.97 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 26.1% | ||||
| Net Profit Margin | 17.5% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Rodec Pharma Limited, buy the company report.
Board of directors of Rodec Pharma Limited
Rodec Pharma has 6 current directors and 5 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Chhaya Gupta Also directs: Rodec Healthcare Private Limited | Director | 18 Nov 1997 | 28 Years 11 Months | Current |
| Utkarsh Gupta | Director | 24 Mar 2023 | 3 Years 7 Months | Current |
| Mukesh Kumar Gupta | Director | 01 Dec 2000 | 25 Years 11 Months | Current |
| Achal Kapoor Also directs: Davangere Sugar Company Limited, Kairosoft AI Solutions Limited, Ems Limited and 5 more | Additional Director | 23 Aug 2025 | 1 Years 2 Months | Current |
| Nikita Sinha Also directs: Kotia Enterprises Limited, Aanjaay Industries Limited, Vinod Texworld Limited and 2 more | Additional Director | 23 Aug 2025 | 1 Years 2 Months | Current |
| Preeti Also directs: Vintage Coffee and Beverages Limited, Rajnish Wellness Limited, Consecutive Commodities Limited and 2 more | Additional Director | 23 Aug 2025 | 1 Years 2 Months | Current |
Charges & borrowings
Open charges
₹142.48 Cr
Satisfied charges
₹8.51 Cr
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 22 Aug 2024 | 100964793 | Hdfc Bank Limited | ₹30 Lakh | Open | |
| 22 Jun 2023 | 100740925 | Hdfc Bank Limited | ₹16.6 Lakh | Open | |
| 29 Dec 2022 | 100660010 | Hdfc Bank Limited | ₹1 Cr | Open | |
| 28 Jun 2022 | 100602715 | Hdfc Bank Limited | ₹140.5 Cr | Open | |
| 19 Nov 2020 | 100390688 | Axis Bank Limited | ₹51.72 Lakh | Open |
To see the full charge records of Rodec Pharma Limited, buy the company report.
Total charge records: 10 View all charges
Deals & funding
Rodec Pharma Limited has 8 deals on record (6 secondary share transfers, 2 funding rounds), with disclosed funding of ₹98.6 Lakh; the latest was in March 2024.
Total deals
8
Secondary share transfers
6
Funding rounds
2
Disclosed funding
₹98.6 Lakh
Deals on record (5 of 8)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Mar 2024 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: Others |
| Feb 2024 | Secondary share transfer | Undisclosed | Buyer: 3 individuals Seller: 2 individuals |
| Mar 2016 | Secondary share transfer | Undisclosed | Buyer: Others Seller: 4 individuals |
| Mar 2013 | Secondary share transfer | Undisclosed | Buyer: 2 individuals Seller: Skand International Private Limited , Vasudev Enterprises Private Limited |
| Mar 2011 | Funding round | ₹50 Lakh | Investors: Vasudev Enterprises Private Limited, Skand International Private Limited |
To see the full deal history of Rodec Pharma Limited, buy the company report.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Rodec Pharma Limited has 150 court cases on record: 139 filed by Rodec Pharma, 11 filed against it. 34 cases are pending and 116 are disposed.
Total cases
150
Filed by the company
139
Filed against the company
11
Pending
34
Disposed
116
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 135 | 2 | 30 |
| High courts | 15 | 9 | 4 |
Cases on record (5 of 150)
| Court | Type of case | Party | Status |
|---|---|---|---|
| High Court of Delhi | Appeal | Filed by the company against M/S Pfizer Ltd & Anr. | Disposed |
| District court, South, Delhi | Interim or miscellaneous application | Filed by the company against M/S Pfizer Ltd. and Ors. | Disposed |
| District court, Ghaziabad, Uttar Pradesh | Criminal case | Filed by the company against M/S Sri Ram Enterprises - Satyam | Pending |
| District court, Ghaziabad, Uttar Pradesh | Criminal case | Filed by the company against an individual | Pending |
| District court, Ghaziabad, Uttar Pradesh | Criminal case | Filed by the company against an individual | Pending |
To see the full case history of Rodec Pharma Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Rodec Pharma Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Rodec Pharma has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 09AABCR5958E1Z5 | Uttar Pradesh | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Rodec Pharma Limited, buy the company report.
Recent activity
Rodec Pharma Limited has 8 board changes on record since 1997: 6 appointments and 2 cessations. The latest: Achal Kapoor was appointed as Additional Director on 23 Aug 2025.
Appointed
Achal Kapoor was appointed as Additional Director.
Appointed
Nikita Sinha was appointed as Additional Director.
Appointed
Preeti was appointed as Additional Director.
Charges
A charge with Hdfc Bank Limited of Rs. 140.50 Cr registered on 28 Jun 2022 with Charge ID 100602715 was modified on 06 May 2025.
AGM
Rodec Pharma Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 0.30 Cr with Charge ID 100964793 was registered on 22 Aug 2024.
Charges
A charge registered on 07 Jul 2022 via Charge ID 100598639 with Axis Bank Limited was fully satisfied on 14 Aug 2024.
Charges
A charge registered on 06 Jul 2022 via Charge ID 100599470 with Axis Bank Limited was fully satisfied on 13 Aug 2024.
Filing
Rodec Pharma Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Delhi.
Ceased
Utkarsh Gupta ceased to be Additional Director.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 0.17 Cr with Charge ID 100740925 was registered on 22 Jun 2023.
Ceased
Shubhangi Gupta ceased to be Director.
17 earlier events are in the company report.
Frequently asked questions
Rodec Pharma is an active public limited company based in New Delhi, Delhi, India. The company works in animal pharmaceuticals and healthcare, within the pharma industry. It was incorporated on 18 November 1997 (29+ years old) and is registered under CIN U24233UP1997PLC239832.
Rodec Pharma has 6 current directors:
- Chhaya Gupta - Director
- Utkarsh Gupta - Director
- Mukesh Kumar Gupta - Director
- Achal Kapoor - Additional Director
- Nikita Sinha - Additional Director
- Preeti - Additional Director
The latest financial statements of Rodec Pharma on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from 2015 are in the company report.
The GSTIN of Rodec Pharma is 09AABCR5958E1Z5, registered in Uttar Pradesh.
The CIN (Corporate Identification Number) of Rodec Pharma is U24233UP1997PLC239832. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Rodec Pharma has 150 court cases on record: 139 filed by the company and 11 filed against it. 34 are pending. Most are in the district courts.
Rodec Pharma was incorporated on 18 November 1997, making it 29+ years old. It is registered with the Registrar of Companies, Delhi.
Rodec Pharma has 8 deals on record (6 secondary share transfers, 2 funding rounds), with disclosed funding of ₹98.6 Lakh; the latest was in March 2024.
Achal Kapoor was appointed as Additional Director on 23 Aug 2025. Nikita Sinha was appointed as Additional Director on 23 Aug 2025. Preeti was appointed as Additional Director on 23 Aug 2025. Rodec Pharma has 8 board changes on record in total.
Yes, Rodec Pharma is registered as an MSME under Udyam registration (number: UDYAM-UP-29-0004143).
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages